ArticleDrug safety2020

Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.

Philippe Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.